Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease

PHASE3RecruitingINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions

Alzheimer DiseaseChronic Traumatic Encephalopathy

Interventions

DRUG

[F-18]Flornaptitril

All participants will receive a single dose of F-18 FNT during an imaging visit.

Trial Locations (1)

RECRUITING

Endeavor Health Systems, Evanston